Logo

Inpharmatica and Ingenuity Pen Co-Marketing Alliance

Mar 20, 2006

NEW YORK, March 20 (GenomeWeb News) - Inpharmatica and Ingenuity Systems today said they have penned a co-marketing alliance for their drug-discovery tools.


Terms of the agreement call for Inpharmatica to co-market its Blu-Chip probe-to-protein assignment module with Ingenuity's Pathway Analysis.

 

The alliance will enable researchers to move through two steps of analysis: probe assignment and protein network analysis, the companies said.

 

Details were not disclosed.

Breaking News
The Scan

Not as High as Hoped

The Associated Press says initial results from a trial of CureVac's SARS-CoV-2 vaccine suggests low effectiveness in preventing COVID-19.

Finding Freshwater DNA

A new research project plans to use eDNA sampling to analyze freshwater rivers across the world, the Guardian reports.

Rise in Payments

Kaiser Health News investigates the rise of payments made by medical device companies to surgeons that could be in violation of anti-kickback laws.

Nature Papers Present Ginkgo Biloba Genome Assembly, Collection of Polygenic Indexes, More

In Nature this week: a nearly complete Ginkgo biloba genome assembly, polygenic indexes for dozens of phenotypes, and more.